chr7-150959701-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 4P and 1B. PM1PP3_ModerateBS2_Supporting
The NM_000238.4(KCNH2):c.343G>A(p.Val115Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000496 in 1,614,182 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000238.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNH2 | NM_000238.4 | c.343G>A | p.Val115Met | missense_variant | Exon 3 of 15 | ENST00000262186.10 | NP_000229.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNH2 | ENST00000262186.10 | c.343G>A | p.Val115Met | missense_variant | Exon 3 of 15 | 1 | NM_000238.4 | ENSP00000262186.5 | ||
KCNH2 | ENST00000532957.5 | n.566G>A | non_coding_transcript_exon_variant | Exon 3 of 9 | 2 | |||||
KCNH2 | ENST00000684241.1 | n.1176G>A | non_coding_transcript_exon_variant | Exon 1 of 13 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152176Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251426Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135906
GnomAD4 exome AF: 0.00000410 AC: 6AN: 1461888Hom.: 0 Cov.: 32 AF XY: 0.00000550 AC XY: 4AN XY: 727246
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152294Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74464
ClinVar
Submissions by phenotype
Long QT syndrome Uncertain:2
An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 115 of the KCNH2 protein (p.Val115Met). This variant is present in population databases (rs150988911, gnomAD 0.01%). This missense change has been observed in individual(s) with long QT syndrome (LQTS) (PMID: 18441445). ClinVar contains an entry for this variant (Variation ID: 67496). Experimental studies have shown that this missense change does not substantially affect KCNH2 function (PMID: 25417810, 32475984). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
This missense variant replaces valine with methionine at codon 115 of the KCNH2 protein. Computational prediction suggests that this variant may have a deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). Electrophysiological functional studies suggest that this variant may not impact KCNH2 activity (PMID: 25417810); the clinical relevance of this observation is not known. This variant has been reported in an individual affected with long QT syndrome (PMID: 18441445). This variant has been identified in 4/251426 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Long QT syndrome 2 Uncertain:1
- -
Cardiovascular phenotype Uncertain:1
The p.V115M variant (also known as c.343G>A), located in coding exon 3 of the KCNH2 gene, results from a G to A substitution at nucleotide position 343. The valine at codon 115 is replaced by methionine, an amino acid with highly similar properties, and is located in the cytoplasmic PAC region. This variant has been detected in long QT syndrome (LQTS) cohorts; however, details were limited and one reported case carried a second variant in a LQTS-related gene (Nagaoka I et al. Circ J, 2008 May;72:694-9; Jiménez-Jáimez J et al. Rev Esp Cardiol (Engl Ed), 2017 Oct;70:808-816). This variant has also been detected in exome cohorts (Amendola LM et al. Genome Res, 2015 Mar;25:305-15). In vitro studies by one group indicated that this variant may not adversely impact protein trafficking or channel function compared to wild type (Anderson CL et al. Nat Commun, 2014 Nov;5:5535). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Short QT syndrome type 1;C3150943:Long QT syndrome 2 Uncertain:1
- -
Cardiac arrhythmia Uncertain:1
This missense variant replaces valine with methionine at codon 115 of the KCNH2 protein. Computational prediction suggests that this variant may have a deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). Electrophysiological functional studies suggest that this variant may not impact KCNH2 activity (PMID: 25417810); the clinical relevance of this observation is not known. This variant has been reported in an individual affected with long QT syndrome (PMID: 18441445). This variant has been identified in 4/251426 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Congenital long QT syndrome Other:1
This variant has been reported as associated with Long QT syndrome in the following publications (PMID:18441445). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at